TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.

about

c-Kit modifies the inflammatory status of smooth muscle cells MK2/3 Are Pivotal for IL-33-Induced and Mast Cell-Dependent Leukocyte Recruitment and the Resulting Skin Inflammation.

P2860

Q33802517-5D73710F-17ED-4958-A0DE-E2D5FD84CE19 Q48326470-647E248B-38B7-4677-B83A-88B76E600A69

P2860

TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.

Item

http://www.wikidata.org/entity/Q36557145

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

TAK1 and IKK2, novel mediators ...... ets for c-Kit-driven diseases.

@ast

TAK1 and IKK2, novel mediators ...... ets for c-Kit-driven diseases.

@en

type

Item

label

TAK1 and IKK2, novel mediators ...... ets for c-Kit-driven diseases.

@ast

TAK1 and IKK2, novel mediators ...... ets for c-Kit-driven diseases.

@en

prefLabel

TAK1 and IKK2, novel mediators ...... ets for c-Kit-driven diseases.

@ast

TAK1 and IKK2, novel mediators ...... ets for c-Kit-driven diseases.

@en

P1476

TAK1 and IKK2, novel mediators ...... gets for c-Kit-driven diseases

@en

P2093

Anne Dudeck

http://www.w3.org/2001/XMLSchema#string

Christiane Göpfert

http://www.w3.org/2001/XMLSchema#string

Dagmar Schütz

http://www.w3.org/2001/XMLSchema#string

Franziska Boelke

http://www.w3.org/2001/XMLSchema#string

Franziska Weber

http://www.w3.org/2001/XMLSchema#string

Julia Ruth

http://www.w3.org/2001/XMLSchema#string

Mandy Rothe

http://www.w3.org/2001/XMLSchema#string

Michaela A Diamanti

http://www.w3.org/2001/XMLSchema#string

Ralf Stumm

http://www.w3.org/2001/XMLSchema#string

Romy Loschinski

http://www.w3.org/2001/XMLSchema#string

P2860

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

Innate immunity and its regulation by mast cells

Stem cell factor and its receptor c-Kit as targets for inflammatory diseases

Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration

P304

28833-28850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281684012

http://www.w3.org/2001/XMLSchema#string

P698

26353931

http://www.w3.org/2001/XMLSchema#string

P932

4745695

http://www.w3.org/2001/XMLSchema#string

TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.

about

P2860

P2860

TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932